SAGE PRO

Home / Research / Dixon Technologies (India) Limited

SAGE PRO · ORIGINAL EQUITY RESEARCH

Dixon Technologies (India) Limited — Q2 FY27 Results Analysis

Reported revenue grew 42%

Published · Quarter Q2 FY27 · DIXON

PeriodQ2 FY27
COMPANY-SPECIFIC GRAPHICAL SUMMARY

What the reported figures reveal

CHART 1

Reported Q2 revenue incl other income

Q2 FY26₹15,351 crore
Q2 FY27₹21,863 crore

https://nsearchives.nseindia.com/corporate/DIXON_30102026161836_OutcomewithPPT30102026.pdf

CHART 2

Reported Q2 EBITDA

Q2 FY26₹1,057 crore
Q2 FY27₹666 crore

https://nsearchives.nseindia.com/corporate/DIXON_30102026161836_OutcomewithPPT30102026.pdf

CHART 3

Adjusted Q2 revenue

Q2 FY26₹14,858 crore
Q2 FY27₹21,806 crore

https://nsearchives.nseindia.com/corporate/DIXON_30102026161836_OutcomewithPPT30102026.pdf

CHART 4

Adjusted Q2 EBITDA

Q2 FY26₹564 crore
Q2 FY27₹609 crore

https://nsearchives.nseindia.com/corporate/DIXON_30102026161836_OutcomewithPPT30102026.pdf

ORIGINAL RESEARCH INSIGHTS

Investment findings and watch points

RESEARCH INSIGHT

Reported revenue grew 42%

Reported Q2 revenue incl other income: 15351 ₹ crore (Q2 FY26) versus 21863 ₹ crore (Q2 FY27). Reported revenue grew 42%.

Watch: Separate other income

RESEARCH INSIGHT

EBITDA declined due to gain-base comparability

Reported Q2 EBITDA: 1057 ₹ crore (Q2 FY26) versus 666 ₹ crore (Q2 FY27). EBITDA declined due to gain-base comparability.

Watch: Maintain fair-value bridge

RESEARCH INSIGHT

Adjusted revenue increased 47%

Adjusted Q2 revenue: 14858 ₹ crore (Q2 FY26) versus 21806 ₹ crore (Q2 FY27). Adjusted revenue increased 47%.

Watch: Check manufacturing yield

RESEARCH INSIGHT

Adjusted EBITDA rose 8%

Adjusted Q2 EBITDA: 564 ₹ crore (Q2 FY26) versus 609 ₹ crore (Q2 FY27). Adjusted EBITDA rose 8%.

Watch: Assess volume margin

FULL PUBLISHED RESEARCH

Earnings and management commentary analysis

September 2026 quarter, Stance WATCH, original issuer evidence. Dixon's reported Q2 FY27 earnings are distorted by different fair-value gains in the comparison periods; the adjusted series gives a very different signal. Reported revenue including other income grew 42% to ₹21,863 crore while reported EBITDA fell 37% to ₹666 crore. Adjusting for the Aditya Infotech fair-value and lighting-transfer gains, revenue including other income rose 47% to ₹21,806 crore, adjusted EBITDA increased 8% to ₹609 crore, and adjusted PAT after noncontrolling interests rose 19% to ₹293 crore. WATCH until working capital and underlying margins stabilize. [S1][S2]

Quantitative investor evidencePrior periodCurrent period
Reported Q2 revenue incl other income15351 ₹ crore (Q2 FY26)21863 ₹ crore (Q2 FY27)
Reported Q2 EBITDA1057 ₹ crore (Q2 FY26)666 ₹ crore (Q2 FY27)
Adjusted Q2 revenue14858 ₹ crore (Q2 FY26)21806 ₹ crore (Q2 FY27)
Adjusted Q2 EBITDA564 ₹ crore (Q2 FY26)609 ₹ crore (Q2 FY27)
Adjusted Q2 margin3.8 % (Q2 FY26)2.8 % (Q2 FY27)
Reported PAT after NCI670 ₹ crore (Q2 FY26)344 ₹ crore (Q2 FY27)
Adjusted PAT after NCI247 ₹ crore (Q2 FY26)293 ₹ crore (Q2 FY27)
H1 reported revenue28188 ₹ crore (H1 FY26)37938 ₹ crore (H1 FY27)

Six source-based investment takeaways: Reported Q2 revenue incl other income: Reported revenue grew 42%. Reported Q2 EBITDA: EBITDA declined due to gain-base comparability. Adjusted Q2 revenue: Adjusted revenue increased 47%. Adjusted Q2 EBITDA: Adjusted EBITDA rose 8%. Adjusted Q2 margin: Core margin contracted one point. Reported PAT after NCI: Reported PAT fell with noncash gains. The separate sourced graphical Investment Briefing is retained ahead of the main seven chapters.

Chapter 1 — Investment thesis, valuation demand and decision

Dixon's reported Q2 FY27 earnings are distorted by different fair-value gains in the comparison periods; the adjusted series gives a very different signal. Reported revenue including other income grew 42% to ₹21,863 crore while reported EBITDA fell 37% to ₹666 crore. Adjusting for the Aditya Infotech fair-value and lighting-transfer gains, revenue including other income rose 47% to ₹21,806 crore, adjusted EBITDA increased 8% to ₹609 crore, and adjusted PAT after noncontrolling interests rose 19% to ₹293 crore. WATCH until working capital and underlying margins stabilize. [S1][S2]

Evidence-based takeaways and monitoring triggers

  • Reported Q2 revenue incl other income: 21863 ₹ crore (Q2 FY27) against 15351 ₹ crore (Q2 FY26). Reported revenue grew 42%; Separate other income. [S2]
  • Reported Q2 EBITDA: 666 ₹ crore (Q2 FY27) against 1057 ₹ crore (Q2 FY26). EBITDA declined due to gain-base comparability; Maintain fair-value bridge. [S2]
  • Adjusted Q2 revenue: 21806 ₹ crore (Q2 FY27) against 14858 ₹ crore (Q2 FY26). Adjusted revenue increased 47%; Check manufacturing yield. [S2]

Analytical interpretation. Reported revenue grew 42%. Investors must separate other income. EBITDA declined due to gain-base comparability. Investors must maintain fair-value bridge. Adjusted revenue increased 47%. Investors must check manufacturing yield. A future management goal is not represented as a historical result. Investors require subsequent period evidence and price-adjusted analysis before making a portfolio decision.

Chapter 2 — Reported Q2/H1 and earnings quality

Reported EBITDA fell from ₹1,057 crore to ₹666 crore, but the adjusted comparison is ₹564 crore to ₹609 crore; mixing the two measures would invert the investment conclusion. The fair-value gain on Dixon's stake in Aditya Infotech was ₹57 crore in Q2 FY27 against ₹465 crore a year earlier, with an additional ₹28 crore lighting undertaking gain in Q2 FY26.

This makes unadjusted PAT growth of negative 49% after NCI less useful than adjusted PAT from ₹247 crore to ₹293 crore. Include both layers, not just the one that flatters the story. [S1][S2]

Evidence-based takeaways and monitoring triggers

  • Adjusted Q2 revenue: 21806 ₹ crore (Q2 FY27) against 14858 ₹ crore (Q2 FY26). Adjusted revenue increased 47%; Check manufacturing yield. [S2]
  • Adjusted Q2 EBITDA: 609 ₹ crore (Q2 FY27) against 564 ₹ crore (Q2 FY26). Adjusted EBITDA rose 8%; Assess volume margin. [S2]
  • Adjusted Q2 margin: 2.8 % (Q2 FY27) against 3.8 % (Q2 FY26). Core margin contracted one point; Monitor product mix. [S2]

Analytical interpretation. Adjusted revenue increased 47%. Investors must check manufacturing yield. Adjusted EBITDA rose 8%. Investors must assess volume margin. Core margin contracted one point. Investors must monitor product mix. A future management goal is not represented as a historical result. Investors require subsequent period evidence and price-adjusted analysis before making a portfolio decision.

Chapter 3 — Product, segment, channel and operating economics

Electronics manufacturing services exposure spans mobile devices, telecom/IT hardware, consumer electronics, and newer device and component programs. Large-volume manufacturing revenue is not comparable with brand-owner gross margins: bill-of-material pass-through, customer pricing and yield drive gross and operating returns. The issuer's quarterly adjusted EBITDA margin was 2.8% versus 3.8% a year earlier even as sales climbed. Capacity expansion and higher value-add are worthwhile only if they improve profit per unit and cash conversion. [S1][S2]

Evidence-based takeaways and monitoring triggers

  • Adjusted Q2 margin: 2.8 % (Q2 FY27) against 3.8 % (Q2 FY26). Core margin contracted one point; Monitor product mix. [S2]
  • Reported PAT after NCI: 344 ₹ crore (Q2 FY27) against 670 ₹ crore (Q2 FY26). Reported PAT fell with noncash gains; Avoid false growth bridge. [S2]
  • Adjusted PAT after NCI: 293 ₹ crore (Q2 FY27) against 247 ₹ crore (Q2 FY26). Adjusted earnings rose 19%; Reconcile minority share. [S2]

Analytical interpretation. Core margin contracted one point. Investors must monitor product mix. Reported PAT fell with noncash gains. Investors must avoid false growth bridge. Adjusted earnings rose 19%. Investors must reconcile minority share. A future management goal is not represented as a historical result. Investors require subsequent period evidence and price-adjusted analysis before making a portfolio decision.

Chapter 4 — Execution projects, management claims and Q&A

Management's Q2 call addressed scale-up and new product/customer relationships, including large electronics outsourcing and IT hardware partnerships. The board announced the appointment of an additional executive director, a governance/leadership event not itself a forecast. Analyst Q&A should focus on contribution from new components, customer mix, utilization, cost of new lines, and whether supply chains can meet higher volumes without disproportionate inventory funding. No contracted capacity is assumed to be fully shipped. [S1][S2]

Evidence-based takeaways and monitoring triggers

  • Adjusted PAT after NCI: 293 ₹ crore (Q2 FY27) against 247 ₹ crore (Q2 FY26). Adjusted earnings rose 19%; Reconcile minority share. [S2]
  • H1 reported revenue: 37938 ₹ crore (H1 FY27) against 28188 ₹ crore (H1 FY26). H1 revenue rose 35%; Compare same periods. [S2]
  • H1 adjusted revenue: 37362 ₹ crore (H1 FY27) against 27695 ₹ crore (H1 FY26). Adjusted H1 sales expanded; Check cash conversion. [S2]

Analytical interpretation. Adjusted earnings rose 19%. Investors must reconcile minority share. H1 revenue rose 35%. Investors must compare same periods. Adjusted H1 sales expanded. Investors must check cash conversion. A future management goal is not represented as a historical result. Investors require subsequent period evidence and price-adjusted analysis before making a portfolio decision.

Chapter 5 — Capital, cash, debt and economic payback

H1 reported revenue including other income was ₹37,938 crore and reported EBITDA ₹1,657 crore. On the adjusted basis H1 revenue was ₹37,362 crore and EBITDA ₹1,081 crore, compared with ₹27,695 crore and ₹1,048 crore last H1. Net working-capital days were shown as 6 versus negative 8 in FY26; net debt was ₹73 crore versus net cash ₹773 crore at the older FY26 reference. A working-capital reversal in a high-sales-volume EMS business can erase the earnings benefit, so track receivables, inventories and cash actually available. [S1][S2]

Evidence-based takeaways and monitoring triggers

  • H1 adjusted revenue: 37362 ₹ crore (H1 FY27) against 27695 ₹ crore (H1 FY26). Adjusted H1 sales expanded; Check cash conversion. [S2]
  • H1 adjusted EBITDA: 1081 ₹ crore (H1 FY27) against 1048 ₹ crore (H1 FY26). H1 adjusted profit rose 3%; Measure operating leverage. [S2]
  • H1 adjusted PAT after NCI: 511 ₹ crore (H1 FY27) against 472 ₹ crore (H1 FY26). H1 adjusted after-NCI profit rose 8%; Monitor taxes. [S2]

Analytical interpretation. Adjusted H1 sales expanded. Investors must check cash conversion. H1 adjusted profit rose 3%. Investors must measure operating leverage. H1 adjusted after-NCI profit rose 8%. Investors must monitor taxes. A future management goal is not represented as a historical result. Investors require subsequent period evidence and price-adjusted analysis before making a portfolio decision.

Chapter 6 — Conditional bull/base/bear and falsifiers

Bull conditions involve higher shipment volumes accompanied by expanding adjusted EBITDA per rupee of sales, stronger component localization and normalizing working capital. Base conditions are revenue growth with compressed percentage margins, reflecting contract manufacturing mix. Bear conditions include persistent low margin, customer pricing power, component shortages or high capital tied in new plants. None of these is a price target, and noncash fair-value gains must remain separately visible. [S1][S2]

Evidence-based takeaways and monitoring triggers

  • Reported Q2 revenue incl other income: 21863 ₹ crore (Q2 FY27) against 15351 ₹ crore (Q2 FY26). Reported revenue grew 42%; Separate other income. [S2]
  • Reported Q2 EBITDA: 666 ₹ crore (Q2 FY27) against 1057 ₹ crore (Q2 FY26). EBITDA declined due to gain-base comparability; Maintain fair-value bridge. [S2]
  • Adjusted Q2 revenue: 21806 ₹ crore (Q2 FY27) against 14858 ₹ crore (Q2 FY26). Adjusted revenue increased 47%; Check manufacturing yield. [S2]

Analytical interpretation. Reported revenue grew 42%. Investors must separate other income. EBITDA declined due to gain-base comparability. Investors must maintain fair-value bridge. Adjusted revenue increased 47%. Investors must check manufacturing yield. A future management goal is not represented as a historical result. Investors require subsequent period evidence and price-adjusted analysis before making a portfolio decision.

Chapter 7 — Investor action plan and quarterly monitoring

WATCH adjusted Q2 EBITDA ₹609 crore and adjusted PAT after NCI ₹293 crore, along with reported figures and the fair-value reconciliation. Monitor sales ₹21,806 crore adjusted, 2.8% adjusted EBITDA margin, the 6 working-capital days and ₹73 crore net debt. The next quarter must clarify whether sales growth is creating cash after investment and minority interests. Upgrade only when core margins and cash returns improve, not because reported fair-value gains move. [S1][S2]

Evidence-based takeaways and monitoring triggers

  • Adjusted Q2 revenue: 21806 ₹ crore (Q2 FY27) against 14858 ₹ crore (Q2 FY26). Adjusted revenue increased 47%; Check manufacturing yield. [S2]
  • Adjusted Q2 EBITDA: 609 ₹ crore (Q2 FY27) against 564 ₹ crore (Q2 FY26). Adjusted EBITDA rose 8%; Assess volume margin. [S2]
  • Adjusted Q2 margin: 2.8 % (Q2 FY27) against 3.8 % (Q2 FY26). Core margin contracted one point; Monitor product mix. [S2]

Analytical interpretation. Adjusted revenue increased 47%. Investors must check manufacturing yield. Adjusted EBITDA rose 8%. Investors must assess volume margin. Core margin contracted one point. Investors must monitor product mix. A future management goal is not represented as a historical result. Investors require subsequent period evidence and price-adjusted analysis before making a portfolio decision.

Original issuer and exchange disclosures

[S1] Dixon Technologies (India) Limited Q2 FY27 earnings-call transcript — issuer management and investor discussion. [S2] Dixon Technologies (India) Limited Q2 FY27 investor presentation — issuer numerical financial and operating results.

Financial units, periods, consolidated or adjusted bases and source dates are retained. No unverified earnings, market price, dividend, target price or net-debt figure is created. Investments and guidance require assessment of actual implementation and cash rather than assuming forecasts are already achieved.

Additional company evidence

CHART 5

Adjusted Q2 margin

Q2 FY263.8%
Q2 FY272.8%

https://nsearchives.nseindia.com/corporate/DIXON_30102026161836_OutcomewithPPT30102026.pdf

CHART 6

Reported PAT after NCI

Q2 FY26₹670 crore
Q2 FY27₹344 crore

https://nsearchives.nseindia.com/corporate/DIXON_30102026161836_OutcomewithPPT30102026.pdf

CHART 7

Adjusted PAT after NCI

Q2 FY26₹247 crore
Q2 FY27₹293 crore

https://nsearchives.nseindia.com/corporate/DIXON_30102026161836_OutcomewithPPT30102026.pdf

CHART 8

H1 reported revenue

H1 FY26₹28,188 crore
H1 FY27₹37,938 crore

https://nsearchives.nseindia.com/corporate/DIXON_30102026161836_OutcomewithPPT30102026.pdf

SOURCE REFERENCES

Original disclosures and investor presentations

  1. Issuer disclosure
  2. Issuer disclosure

Related research and comparisons

Other published Q2 FY27 reports

This is dated research, not a live market quote. Scenarios and historical performance are not guarantees.